InferRead DR Tuberculosis

Infervision
Information source: Public
Last updated: Sept. 1, 2021

General Information

General
Product name InferRead DR Tuberculosis
Company Infervision
Subspeciality Chest
Modality X-ray
Disease targeted Tuberculosis
Key-features Tuberculosis detection
Suggested use

Technical Specifications

Data characteristics
Population
Input
Input format
Output
Output format
Technology
Integration
Deployment
Trigger for analysis
Processing time

Regulatory

Certification
CE
Certified, Class IIa , MDD
FDA No or not yet
Intended Use Statements
Intended use (according to CE) The design, Development and Manufacture of Computer aided diagnostic software for viewing and analyzing DICOM images to assist physicians with abnormality detection and diagnosis.

Market

Market presence
On market since 01-2020
Distribution channels Stop TB Partnership Global Drug Facility
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on

Evidence

Evidence
Peer reviewed papers on performance

  • Tuberculosis detection from chest x-rays for triaging in a high tuberculosis-burden setting: an evaluation of five artificial intelligence algorithms (read)
Non-peer reviewed papers on performance
Other relevant papers